Tsimikas S - Search Results

1

Lipoprotein(a) and coronary artery calcium in comparison with other lipid biomarkers: The multi-ethnic study of atherosclerosis.

Jackson CL, Garg PK, Guan W, Tsai MY, Criqui MH, Tsimikas S, Bhatia HS. Jackson CL, et al. Among authors: tsimikas s. J Clin Lipidol. 2023 Jul-Aug;17(4):538-548. doi: 10.1016/j.jacl.2023.06.002. Epub 2023 Jun 17. J Clin Lipidol. 2023. PMID: 37357049 Free PMC article.

2

The role of dietary fatty acids in lipoprotein oxidation and atherosclerosis.

Tsimikas S, Reaven PD. Tsimikas S, et al. Curr Opin Lipidol. 1998 Aug;9(4):301-7. doi: 10.1097/00041433-199808000-00003. Curr Opin Lipidol. 1998. PMID: 9739484 Review.

3

Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease.

Fraley AE, Tsimikas S. Fraley AE, et al. Among authors: tsimikas s. Curr Opin Lipidol. 2006 Oct;17(5):502-9. doi: 10.1097/01.mol.0000245255.40634.b5. Curr Opin Lipidol. 2006. PMID: 16960498 Review.

4

Emerging therapeutic agents to lower lipoprotein (a) levels.

Kolski B, Tsimikas S. Kolski B, et al. Among authors: tsimikas s. Curr Opin Lipidol. 2012 Dec;23(6):560-8. doi: 10.1097/MOL.0b013e3283598d81. Curr Opin Lipidol. 2012. PMID: 23041907 Review.

5

JCL Roundtable: Should we treat elevations in Lp(a)?

Brown WV, Moriarty PM, Remaley AT, Tsimikas S. Brown WV, et al. Among authors: tsimikas s. J Clin Lipidol. 2016 Mar-Apr;10(2):215-24. doi: 10.1016/j.jacl.2016.02.012. Epub 2016 Mar 5. J Clin Lipidol. 2016. PMID: 27055952

6

Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a).

Yeang C, Hung MY, Byun YS, Clopton P, Yang X, Witztum JL, Tsimikas S. Yeang C, et al. Among authors: tsimikas s. J Clin Lipidol. 2016 May-Jun;10(3):594-603. doi: 10.1016/j.jacl.2016.01.005. Epub 2016 Mar 8. J Clin Lipidol. 2016. PMID: 27206947 Clinical Trial.

7

Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemia.

Duell PB, Santos RD, Kirwan BA, Witztum JL, Tsimikas S, Kastelein JJP. Duell PB, et al. Among authors: tsimikas s. J Clin Lipidol. 2016 Jul-Aug;10(4):1011-1021. doi: 10.1016/j.jacl.2016.04.013. Epub 2016 May 9. J Clin Lipidol. 2016. PMID: 27578134 Clinical Trial.

8

Lipoprotein(a)-cholesterol levels estimated by vertical auto profile correlate poorly with Lp(a) mass in hyperlipidemic subjects: Implications for clinical practice interpretation of Lp(a)-mediated risk.

Yeang C, Clopton PC, Tsimikas S. Yeang C, et al. Among authors: tsimikas s. J Clin Lipidol. 2016 Nov-Dec;10(6):1389-1396. doi: 10.1016/j.jacl.2016.09.012. Epub 2016 Sep 28. J Clin Lipidol. 2016. PMID: 27919356 Free PMC article. Clinical Trial.

9

Temporal variability in lipoprotein(a) levels in patients enrolled in the placebo arms of IONIS-APO(a)_Rx and IONIS-APO(a)-L_Rx antisense oligonucleotide clinical trials.

Marcovina SM, Viney NJ, Hughes SG, Xia S, Witztum JL, Tsimikas S. Marcovina SM, et al. Among authors: tsimikas s. J Clin Lipidol. 2018 Jan-Feb;12(1):122-129.e2. doi: 10.1016/j.jacl.2017.10.024. Epub 2017 Nov 2. J Clin Lipidol. 2018. PMID: 29174389 Clinical Trial.

10

Interleukin-1 genotypes modulate the long-term effect of lipoprotein(a) on cardiovascular events: The Ioannina Study.

Naka KK, Bechlioullis A, Marini A, Sionis D, Vakalis K, Triantis G, Wilkins L, Rogus J, Kornman KS, Witztum JL, Doucette-Stamm L, Michalis LK, Tsimikas S. Naka KK, et al. Among authors: tsimikas s. J Clin Lipidol. 2018 Mar-Apr;12(2):338-347. doi: 10.1016/j.jacl.2017.12.004. Epub 2017 Dec 19. J Clin Lipidol. 2018. PMID: 29310992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

376 results

Search Page